Search research articles
Contact Us
Filters
Showing results (521-530 of 558) with videos related to
Page
of 56
Sort By:
Breast (Edinburgh, Scotland)
|
April 10, 2014
Breast cancer screening halves the risk of breast cancer death: a case-referent study
Ellen Paap, André L M Verbeek, Anita A M Botterweck, et al.
Molecular Medicine (Cambridge, Mass.)
|
February 2, 2024
A reliable transcriptomic risk-score applicable to formalin-fixed paraffin-embedded biopsies improves outcome prediction in localized prostate cancer
Michael Rade, Markus Kreuz, Angelika Borkowetz, et al.
Journal of Medicinal Chemistry
|
September 18, 2010
Discovery of a β-d-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus
Michael J Sofia, Donghui Bao, Wonsuk Chang, et al.
Cancer Medicine
|
September 4, 2018
Patient choice for high-volume center radiation impacts head and neck cancer outcome
Arash O Naghavi, Michelle I Echevarria, Tobin J Strom, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 16, 2012
β-D-2'-α-F-2'-β-C-Methyl-6-O-substituted 3',5'-cyclic phosphate nucleotide prodrugs as inhibitors of hepatitis C virus replication: a structure-activity relationship study
Jinfa Du, Donghui Bao, Byoung-Kwon Chun, et al.
Antimicrobial Agents and Chemotherapy
|
March 30, 2011
Inhibition of hepatitis C virus replicon RNA synthesis by PSI-352938, a cyclic phosphate prodrug of β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methylguanosine
Angela M Lam, Christine Espiritu, Eisuke Murakami, et al.
Journal of Neural Engineering
|
September 27, 2019
Neural engineering: the process, applications, and its role in the future of medicine
Evon S Ereifej, Courtney E Shell, Jonathon S Schofield, et al.
Antimicrobial Agents and Chemotherapy
|
April 18, 2002
DPC 817: a cytidine nucleoside analog with activity against zidovudine- and lamivudine-resistant viral variants
Raymond F Schinazi, John Mellors, Holly Bazmi, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of PSI-353661, a Novel Purine Nucleotide Prodrug for the Treatment of HCV Infection
Wonsuk Chang, Donghui Bao, Byoung-Kwon Chun, et al.
Antimicrobial Agents and Chemotherapy
|
April 25, 2012
Metabolic activation of the anti-hepatitis C virus nucleotide prodrug PSI-352938
Congrong Niu, Tatiana Tolstykh, Haiying Bao, et al.
Page
of 56
Search research articles
Search
Showing results (521-530 of 558) with videos related to
Sort By:
Page
of 56
Breast (Edinburgh, Scotland)
|
April 10, 2014
Breast cancer screening halves the risk of breast cancer death: a case-referent study
Ellen Paap, André L M Verbeek, Anita A M Botterweck, et al.
Molecular Medicine (Cambridge, Mass.)
|
February 2, 2024
A reliable transcriptomic risk-score applicable to formalin-fixed paraffin-embedded biopsies improves outcome prediction in localized prostate cancer
Michael Rade, Markus Kreuz, Angelika Borkowetz, et al.
Journal of Medicinal Chemistry
|
September 18, 2010
Discovery of a β-d-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus
Michael J Sofia, Donghui Bao, Wonsuk Chang, et al.
Cancer Medicine
|
September 4, 2018
Patient choice for high-volume center radiation impacts head and neck cancer outcome
Arash O Naghavi, Michelle I Echevarria, Tobin J Strom, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 16, 2012
β-D-2'-α-F-2'-β-C-Methyl-6-O-substituted 3',5'-cyclic phosphate nucleotide prodrugs as inhibitors of hepatitis C virus replication: a structure-activity relationship study
Jinfa Du, Donghui Bao, Byoung-Kwon Chun, et al.
Antimicrobial Agents and Chemotherapy
|
March 30, 2011
Inhibition of hepatitis C virus replicon RNA synthesis by PSI-352938, a cyclic phosphate prodrug of β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methylguanosine
Angela M Lam, Christine Espiritu, Eisuke Murakami, et al.
Journal of Neural Engineering
|
September 27, 2019
Neural engineering: the process, applications, and its role in the future of medicine
Evon S Ereifej, Courtney E Shell, Jonathon S Schofield, et al.
Antimicrobial Agents and Chemotherapy
|
April 18, 2002
DPC 817: a cytidine nucleoside analog with activity against zidovudine- and lamivudine-resistant viral variants
Raymond F Schinazi, John Mellors, Holly Bazmi, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of PSI-353661, a Novel Purine Nucleotide Prodrug for the Treatment of HCV Infection
Wonsuk Chang, Donghui Bao, Byoung-Kwon Chun, et al.
Antimicrobial Agents and Chemotherapy
|
April 25, 2012
Metabolic activation of the anti-hepatitis C virus nucleotide prodrug PSI-352938
Congrong Niu, Tatiana Tolstykh, Haiying Bao, et al.
Page
of 56